Caligor Rx Names Michael P. Dallmann as Director of Strategic Planning

Seasoned Supply Chain Management Executive to Help Lead Company’s Strategic Growth Initiatives

SECAUCUS, N.J.--()--Caligor Rx, a leading provider of services that enable pharmaceutical and biotechnology companies to maximize the value of their clinical supply chain investments, today announced that it has named Michael P. Dallmann as Director of Strategic Planning, a new position for the Company. Mr. Dallmann, who served as Director, Global Clinical Trial Supply for Cubist Pharmaceuticals, will be responsible for developing and implementing Caligor’s strategy across all lines of business, including comparator sourcing, TrialAssist™ and Global Access Programs.

“His international product development background and the strong relationships he has established over more than two decades in the life sciences industry will serve us well as we continue to expand our services across Europe and Asia.”

“Mike is an experienced leader who brings the ideal complement of strategic skills to support our growing business,” said Caligor Managing Director Tammy Bishop. “His international product development background and the strong relationships he has established over more than two decades in the life sciences industry will serve us well as we continue to expand our services across Europe and Asia.”

Prior to joining Cubist in 2013, Mr. Dallmann worked for Forest Laboratories subsidiary Cerexa, Inc., most recently as Associate Director – Global Pharmacy and Logistics Management and before that as Associate Director – Clinical Trial Supplies. There he was responsible for the development of processes, operating procedures and strategies for the planning and execution of all studies. In addition, he served as Associate Director – R&D Project Planning for Peninsula Pharmaceuticals, Inc., a Johnson & Johnson company. From 2001 to 2003, Mr. Dallmann was Project Manager, Clinical Trial Materials at Elan Pharmaceuticals, Inc. Early in his career he was a Research & Development Scientist for Oral-B Laboratories. Mr. Dallmann received a bachelor’s degree in biochemistry from the University of Guelph in Ontario, Canada.

“I am delighted to join Caligor and look forward to helping to shape and execute the Company’s long-term strategic objectives,” Mr. Dallmann said. “Through its comparator programs, Caligor has established an outstanding global reputation marked by the depth of its regulatory expertise, the strength of its relationships with manufacturers and suppliers and the quality of its values. It’s a privilege to be part of this growing organization.”

About Caligor Rx
Caligor Rx is a global specialty pharmaceuticals services business focused primarily on sourcing and supplying drugs for worldwide clinical trials. The Company is dedicated to serving the pharmaceutical and life science industries as well as patients with specialty needs. To learn more about implementing a Global Access Program, contact Caligor at (212) 988-0590 or CaligorGAP@caligorrx.com.

Contacts

Sharon Merrill Associates
Scott Solomon, 617-542-5300
Senior Vice President
ssolomon@investorrelations.com